rs2274319 — MEF2D

MEF2D and Migraine — When Synapse Regulation Goes Wrong

Your brain maintains a precise balance between neuronal excitation and inhibition. When that balance shifts toward excess excitation — particularly in the cortex — it can trigger cortical spreading depression¹¹ cortical spreading depression
a slow wave of neuronal depolarisation that propagates across the cortex and is thought to underlie migraine aura and activate the trigeminal pain system. The gene MEF2D sits at a critical control point in this system: it is a transcription factor that governs how many excitatory synapses neurons maintain and how quickly they eliminate redundant connections.

The intronic variant rs2274319 is one of the most robustly replicated migraine risk variants in human genetics. The C allele, carried by roughly 64% of people globally, is associated with increased migraine susceptibility in the largest migraine GWAS ever conducted — 102,084 cases and 771,257 controls. The effect size is modest (OR=1.075 per C allele) but the statistical signal is overwhelming (P=3.0×10⁻⁴¹), placing the MEF2D locus among the most robustly confirmed migraine genes identified to date.

The Mechanism

MEF2D (myocyte enhancer factor 2D) is a calcium-activated transcription factor that is selectively expressed in post-mitotic neurons, where it regulates two fundamental processes: neuronal survival during development²² neuronal survival during development
MEF2D activates anti-apoptotic gene programs when calcium signals indicate a neuron has made appropriate synaptic connections, and excitatory synapse pruning in mature neurons.

The synapse regulation function is particularly relevant to migraine. MEF2 factors act as brakes on excitatory synapse number³³ brakes on excitatory synapse number
in an activity-dependent manner, MEF2 restricts how many AMPA-receptor-bearing synapses a neuron maintains, preventing runaway excitatory connectivity. When MEF2D is less active, neurons retain more excitatory synapses than they would otherwise. In hippocampal CA1 neurons, MEF2A/D specifically controls synapse silencing during brief burst firing⁴⁴ synapse silencing during brief burst firing
brief 1-hour periods of postsynaptic bursting selectively depress AMPA receptor transmission in a MEF2A/D-dependent manner, the first stage of synapse elimination. Loss of this function leaves excitatory circuits less able to self-regulate after periods of high activity.

The rs2274319 variant lies within an intron of MEF2D and is thought to affect regulatory elements governing MEF2D expression levels — not the protein sequence itself. The effect is gene-dosage: each C allele is associated with a small but measurable shift in migraine susceptibility, consistent with modest changes in MEF2D transcriptional activity in neurons that matter for migraine — cortical neurons and trigeminal ganglion neurons, where MEF2D is expressed and where excitability thresholds determine migraine vulnerability.

The Evidence

The primary evidence comes from Hautakangas et al. 2022⁵⁵ Hautakangas et al. 2022
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nature Genetics, a landmark meta-GWAS that found rs2274319 at the MEF2D locus to be one of the top variants by effect size across all 123 identified loci (OR=1.075, P=3.0×10⁻⁴¹). This places MEF2D in the same tier as CALCA/CALCB (the gene encoding CGRP, the target of all currently approved migraine preventive biologics) and TRPM8 in terms of statistical reliability.

The MEF2D locus was first identified by the Freilinger et al. 2012⁶⁶ Freilinger et al. 2012
International Headache Genetics Consortium GWAS of migraine without aura. Nature Genetics consortium (combined P=7.06×10⁻¹¹ at the lead SNP rs3790455), and has been replicated in Chinese cohorts by An et al. 2017⁷⁷ An et al. 2017
Clinical Genetics (n=1,114; MEF2D variants significantly differentiated migraine cases from controls, especially for migraine without aura). The cross-ancestry replication strengthens confidence that the MEF2D association reflects a true biological effect rather than a population-specific artefact.

The mechanistic basis is supported by three independent experimental studies. Akhtar et al. 2012⁸⁸ Akhtar et al. 2012
PLoS One demonstrated using conditional knockout mice that MEF2A/D double deficiency produces impaired motor coordination and altered synaptic transmission, while triple MEF2A/C/D knockout causes frank neuronal apoptosis — showing that MEF2D is required for both synaptic homeostasis and neuronal survival. Chang et al. 2017⁹⁹ Chang et al. 2017
eLife pinpointed MEF2A/D as specifically required for activity-dependent AMPA receptor depression during burst firing in hippocampal neurons. Andzelm et al. 2019¹⁰¹⁰ Andzelm et al. 2019
Cell Reports showed that MEF2D (not MEF2A) is the specific isoform required for long-term synaptic depression in cerebellar Purkinje cells, and that MEF2 family members generally restrict excitatory synapse number during development.

Practical Actions

For C allele carriers (CT or CC genotype), the elevated migraine risk from the MEF2D locus is not modifiable in the sense that you cannot change your genotype. However, knowing you carry an increased baseline susceptibility does have practical implications: it informs how aggressively to pursue acute treatment, whether to consider preventive therapy, and which triggers to track carefully.

The MEF2D biology points toward excitability management as the core principle. Magnesium plays a specific role here — it is an NMDA receptor channel blocker and the only supplement with established clinical evidence for migraine prevention in randomised trials, mechanistically aligned with reducing excitatory synapse transmission. Riboflavin (vitamin B2) supports mitochondrial function in neurons and has RCT evidence for migraine prevention as well.

Interactions

rs2274319 is one of several genetic factors influencing migraine susceptibility in the neurology-cognition category. rs10166942 (TRPM8) encodes the cold-sensing ion channel that mediates the "ice cream headache" phenomenon and shows sex-specific migraine associations. rs1835740 near MTDH/PGCP affects glutamate homeostasis via the glial transporter pathway, a converging mechanism — excess synaptic glutamate and reduced MEF2D-mediated synapse elimination both shift cortical networks toward hyperexcitability. The combination of MEF2D CC genotype with other cortical excitability variants is worth noting to a neurologist when discussing preventive migraine therapy.